[New chemotherapy regimens for advanced bladder cancer].
作者信息
Fagbemi S O, Stadler W M
机构信息
Department of Medicine, University of Chicago, IL, USA.
出版信息
Actas Urol Esp. 1998 Jun;22(6):548-9.
PMID:9734137
Abstract
摘要
相似文献
1
[New chemotherapy regimens for advanced bladder cancer].
Actas Urol Esp. 1998 Jun;22(6):548-9.
2
Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
Prog Clin Biol Res. 1990;353:143-52.
3
Successful treatment of metastatic small cell carcinoma of the bladder with methotrexate, vinblastine, doxorubicin and cisplatin therapy.甲氨蝶呤、长春碱、阿霉素和顺铂联合治疗转移性膀胱小细胞癌取得成功。
J Urol. 1995 Feb;153(2):417-9. doi: 10.1097/00005392-199502000-00040.
4
[Preoperative chemotherapy of locally disseminated cancer of the urinary bladder using methotrexate, vinblastine, platidiam and farmorubicin].
Urol Nefrol (Mosk). 1988 Mar-Apr(2):38-41.
5
Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
Semin Urol. 1993 May;11(2):69-73.
6
Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.浸润性膀胱癌的新辅助化疗。局部肿瘤反应的预后价值。
Prog Clin Biol Res. 1989;303:541-7.
7
8
Possible alternative treatment for advanced transitional cell carcinoma of the urothelium (N+ and/or M+) in 1988.
Prog Clin Biol Res. 1989;303:617-9.
9
Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.新辅助化疗尚未成为肌层浸润性膀胱癌的标准治疗方法。
J Clin Oncol. 2001 Sep 15;19(18 Suppl):21S-26S.
10
Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?浸润性膀胱癌的新辅助治疗：是否值得？
Acta Urol Belg. 1996 May;64(2):39-42.
Zotero 插件